Apyx Medical Corporation (APYX) News

Apyx Medical Corporation (APYX): $5.61

-0.25 (-4.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter APYX News Items

APYX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

APYX News Highlights

  • For APYX, its 30 day story count is now at 5.
  • Over the past 21 days, the trend for APYX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.

Latest APYX News From Around the Web

Below are the latest news stories about Apyx Medical Corp that investors may wish to consider to help them evaluate APYX as an investment opportunity.

Apyx Medical Submits Additional FDA 510(k) For Expanded Use Of Renuvion In Dermatological Procedures

Apyx Medical Corporation (NASDAQ: APYX) announced the publication of an article in a journal featuring the results of its U.S. IDE study evaluating the Renuvion Dermal Handpiece using Apyx's Helium Plasma Technology for dermal resurfacing procedures. The Company has also submitted a 510(k) premarket notification to the FDA. The primary efficacy endpoint was achieved, with 100% of the study's subjects achieving a more than a 1-point improvement on the Fitzpatrick Wrinkle and Elastosis Scale (FWS)

Yahoo | February 17, 2022

Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures

CLEARWATER, Fla., February 17, 2022--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices, and supplier and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced the publication of a peer-reviewed article in the journal, Lasers in Surgery and Medicine, the official journal of the American Society for Laser Medicine & Surgery, featuring the results of its

Yahoo | February 17, 2022

A Look At The Intrinsic Value Of Apyx Medical Corporation (NASDAQ:APYX)

Today we will run through one way of estimating the intrinsic value of Apyx Medical Corporation ( NASDAQ:APYX ) by...

Yahoo | February 15, 2022

InMode: Initiates Coverage With Hold Rating Prior To FY21 Earnings Release

On February 10, 2022, Israel-based InMode (NASDAQ:INMD) will report its financial results for FY21. While the company published preliminary results on January 12, 2022, a couple of data points still need additional color. In this analysis, Arenberg Capital provides a brief general overview of the company, what items to look...

Arenberg Equity Research on Seeking Alpha | February 7, 2022

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022

CLEARWATER, Fla., January 27, 2022--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the fourth quarter and fiscal year 2021 will be released before the market opens on Thursday, March 17th.

Yahoo | January 27, 2022

Medtronic (MDT) Undertakes Investment to Advance STEM Education

The Medtronic Foundation, solely funded by Medtronic plc (MDT), entered into 13 new partnerships to bridge the inequity in STEM education among underrepresented and underserved communities.

Yahoo | January 24, 2022

Ensign Group (ENSG) Up 7.4% in 3 Months: More Growth Ahead?

Ensign Group (ENSG) is likely to keep growing on the back of Skilled services and impressive financial strength.

Yahoo | January 19, 2022

Molina Healthcare (MOH) Up 14.4% in 6 Months: Growth Ahead?

Molina Healthcare (MOH) is likely to keep growing on the back of increasing membership and higher premium revenues.

Yahoo | January 18, 2022

Select Medical (SEM) '21 Sales View Up, Labor Costs Ail Profits

Select Medical Holdings (SEM) estimates net operating revenues for 2021 to be $6.2 billion, up from the previous expectations.

Yahoo | January 18, 2022

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results

CLEARWATER, Fla., January 10, 2022--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2021.

Yahoo | January 10, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3965 seconds.